Inventor · Vista, CA, US

John Carter

22Patents
6h-index
23Co-inventors
69Inventor score

Filing activity: Jun 24, 1983 → Sep 28, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US10166183B2 Pharmaceutical formulations Human Necessities 20 Active
US9233959B2 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 Chemistry; Metallurgy 16 Active
US9296739B2 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 Chemistry; Metallurgy 11 Active
US9346800B2 Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 Chemistry; Metallurgy 9 Active
US5001160A 1-aryl-1-hydroxy-1-substitute d-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders Chemistry; Metallurgy 6 Expired
US9814708B2 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 Chemistry; Metallurgy 6 Active
US4877779A 2-aminomethylalkynylalkyl-1,3-dithiane derivatives Chemistry; Metallurgy 3 Expired
US9550780B2 Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 Chemistry; Metallurgy 2 Active
US9907780B2 Low-dose doxepin formulations and methods of making and using the same Human Necessities 1 Active
US9532971B2 Low-dose doxepin formulations and methods of making and using the same Human Necessities 1 Active
US4975437A Isomers of 1-azabicyclo(2.2.2)oct-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboxylate Chemistry; Metallurgy 1 Expired
US4540814A 1,4-Dimethoxy naphthalenecarboxamide anticonvulsants Chemistry; Metallurgy 1 Expired
US4831019A Pharmaceutical preparations of 4-demethoxy-n-trifluoroacetyl anthracyclines Human Necessities 0 Expired
US11666566B2 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 Chemistry; Metallurgy 0 Active
US12100521B2 Nuclear reactor flow control devices and associated reactors, components, and methods Emerging Cross-Sectional Technologies 0 Active
US7939109B1 Method of treating neoplastic disease in a human or animal patient Human Necessities 0 Expired
US11096920B2 Low-dose doxepin formulations and methods of making and using the same Human Necessities 0 Active
US10966922B2 Pharmaceutical formulations Human Necessities 0 Active
US4590063A Anticonvulsants Emerging Cross-Sectional Technologies 0 Expired
US10548871B2 Low-dose doxepin formulations and methods of making and using the same Human Necessities 0 Active
US11033540B2 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 Chemistry; Metallurgy 0 Active
US7758899B2 Pharmaceutical compositions and their use in the treatment of neoplastic disease Human Necessities 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.